Add like
Add dislike
Add to saved papers

Predicting HIV infection in the decade (2005-2015) pre-COVID-19 in Zimbabwe: A supervised classification-based machine learning approach.

The burden of HIV and related diseases have been areas of great concern pre and post the emergence of COVID-19 in Zimbabwe. Machine learning models have been used to predict the risk of diseases, including HIV accurately. Therefore, this paper aimed to determine common risk factors of HIV positivity in Zimbabwe between the decade 2005 to 2015. The data were from three two staged population five-yearly surveys conducted between 2005 and 2015. The outcome variable was HIV status. The prediction model was fit by adopting 80% of the data for learning/training and 20% for testing/prediction. Resampling was done using the stratified 5-fold cross-validation procedure repeatedly. Feature selection was done using Lasso regression, and the best combination of selected features was determined using Sequential Forward Floating Selection. We compared six algorithms in both sexes based on the F1 score, which is the harmonic mean of precision and recall. The overall HIV prevalence for the combined dataset was 22.5% and 15.3% for females and males, respectively. The best-performing algorithm to identify individuals with a higher likelihood of HIV infection was XGBoost, with a high F1 score of 91.4% for males and 90.1% for females based on the combined surveys. The results from the prediction model identified six common features associated with HIV, with total number of lifetime sexual partners and cohabitation duration being the most influential variables for females and males, respectively. In addition to other risk reduction techniques, machine learning may aid in identifying those who might require Pre-exposure prophylaxis, particularly women who experience intimate partner violence. Furthermore, compared to traditional statistical approaches, machine learning uncovered patterns in predicting HIV infection with comparatively reduced uncertainty and, therefore, crucial for effective decision-making.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app